Welcome
Gulf Coast Cancer Centers provide innovative cancer treatment services in Southeast Houston and Pasadena Texas. Our cutting edge technologies include IMRT/IGRT radiation therapy, prostate implants and brachytherapy, chemotherapy and infusion as well as the latest in diagnostic imaging capabilities such PET scans. Our intimate state of the art facilities are helping patients in rural communities receive treatment options that are right for them in one convenient location without the added stress of traveling to large metropolitan areas.
Latest Cancer News
Cervical Cancer Screening Guidelines Updated
(03-21-2012)
According to updated recommendations from the US Preventive Services Task Force, options for cervical cancer screening include a Pap test every three years for women between the ages of 21 and 65, or—for... Continue Reading
Combination of Herceptin and Tykerb May Provide Breast Cancer Benefit (03-20-2012)
For the neoadjuvant (before surgery) treatment of HER2-positive breast cancer, a combination of Herceptin® (trastuzumab) and Tykerb® (lapatinib) may be more effective than either drug alone. These results... Continue Reading
Zelboraf Improves Melanoma Survival (03-16-2012)
Among patients with previously treated metastatic melanoma that carries a certain gene mutation, the targeted drug Zelboraf® (vemurafenib) resulted in a median overall survival of 16 months. This is a... Continue Reading
According to updated recommendations from the US Preventive Services Task Force, options for cervical cancer screening include a Pap test every three years for women between the ages of 21 and 65, or—for... Continue Reading
Combination of Herceptin and Tykerb May Provide Breast Cancer Benefit (03-20-2012)
For the neoadjuvant (before surgery) treatment of HER2-positive breast cancer, a combination of Herceptin® (trastuzumab) and Tykerb® (lapatinib) may be more effective than either drug alone. These results... Continue Reading
Zelboraf Improves Melanoma Survival (03-16-2012)
Among patients with previously treated metastatic melanoma that carries a certain gene mutation, the targeted drug Zelboraf® (vemurafenib) resulted in a median overall survival of 16 months. This is a... Continue Reading
More Cancer News
Types of Cancer
More Cancer Types
Locations
Houston Office
12811 Beamer Rd.
Houston, TX 77089
Phone: 713-474-1414
Fax: 713-474-8477
Pasadena Office
4235 Spencer Hwy
Pasadena, TX 77504
Phone: 713-941-5400
Fax: 713-941-3777